Synergistic effect of IL-1β and TNF-α polymorphisms on the H. pylori-related gastric pre-malignant condition

Hepato-Gastroenterology

Volumn 59, Issue 120, 2012, Pages 2416-2420

  Tahara, Tomomitsu ^a   Shibata, Tomoyuki ^a   Yamashita, Hiromi ^a   Yoshioka, Daisuke ^a   Okubo, Masaaki ^a   Yonemura, Joh ^a   Kamiya, Yoshio ^a   Ishizuka, Takamitsu ^a   Nakagawa, Yoshihito ^a   Nagasaka, Mitsuo ^a   Iwata, Masami ^a   Nakamura, Masakatsu ^b   Hirata, Ichiro ^a   Arisawa, Tomiyasu ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Gastric atrophy; Helicobacter pylori; Interleukin 1 ; Polymorphism; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ATROPHIC GASTRITIS; CELL INFILTRATION; FEMALE; GASTRITIS; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METAPLASIA; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84872072261     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge10605     Document Type: Article

References (25)

1. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. JAMA 1992; 272:65-69.
2. Uemura N, Okamoto S, Yamamoto S, et al.: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784-789.
3. Parsonnet J, Friedman GD, Vandersteen DP, et al.: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127-1131.
4. Huang JQ, Sridhar S, Chen Y, Hunt RH: Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114:1169-1179.
5. Blaser MJ, Parsonnet J: Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994; 94:4-8.
6. Wang M, Furuta T, Takashima M, et al.: Relation between interleukin-1beta messenger RNA in gastric fundic mucosa and gastric juice pH in patients infected with Helicobacter pylori. J Gastroenterol. 1999; 34(11):10-17.
7. Yamaoka Y, Kita M, Kodama T, et al.: Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 1997; 41:442-451.
8. Hwang IR, Kodama T, Kikuchi S, et al.: Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002; 123:1793-1803.
9. Wallace JL, Cucala M, Mugridge K, Parente L: Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 1991; 261:G559-564.
10. Zeng ZR, Hu PJ, Hu S, et al.: Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 2003; 52:1684-1689.
11. El-Omar EM, Carrington M, Chow WH, et al.: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402 (correction published in Nature 2001;412:99).
12. Figueiredo C, Machado JC, Pharoah P, et al.: Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94:1680-1687.
13. Machado JC, Pharoah P, Sousa S, et al.: Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121:823-829.
14. Higuchi T, Seki N, Kamizono S, et al.: Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998; 51:605-612.
15. Soga Y, Nishimura F, Ohyama H, Maeda H, Takashiba S, Murayama Y: Tumor necrosis factor-alpha gene (TNF-alpha) -1031/-863-857 single-nucleotide polymorphisms (SNPs) are associated with severe adult periodontitis in Japanese. J Clin Periodontol 2003; 30:524-531.
16. Sugimoto M, Furuta T, Shirai N, et al.: Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. J Gastroenterol Hepatol 2007; 22:51-59.
17. Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukura N: Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J Gastroenterol 2001; 36:696-699.
18. Lee KA, Ki CS, Kim HJ, et al.: Novel interleukin 1B polymorphism increased the risk of gastric cancer in Korean populations. J Gastroenterol 2004; 39:429-433.
19. Yang J, Hu Z, Xu Y, et al.: Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett 2004; 215:191-198.
20. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis: the updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. AmJ Surg Pathol 1996; 20:1161-1181.
21. Kimura K, Takemoto T: An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1973; 5:21-26.
22. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H: Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123:92-105.
23. Hamajima N, Matsuo K, Saito T, et al.: Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res 2001; 92:383-389.
24. Takashima M, Furuta T, Hanai H, Sugimura H, Kaneko E: Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut 2001; 41:765-773.
25. Rad R, Prinz C, Neu B, et al.: Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 2003; 188:272-281.